Loading...
XHKG
2453
, Last price  
HKD
Name

Concord Healthcare Group Co Ltd

Chart & performance

D1W1MN
XHKG:2453 chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
0.87%
Rev. 5Y
21.92%
Div Yld LY
—
Div Yld TTM
—
Revenues
448m
+15.38%
126,484,567166,321,000470,505,000472,170,000538,650,000388,305,000448,018,708
Net income
-250m
L-43.60%
-280,550,806-583,261,000-816,593,000-541,404,000-373,090,000-443,223,000-249,961,829
CFO
-113m
L-39.19%
-353,932,46950,638,000151,234,000-93,637,000201,853,000-185,964,000-113,082,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
IPO date
Jan 09, 2024
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT